HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization

J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):184-93. doi: 10.1097/00126334-200002010-00011.

Abstract

The Brazilian Network for HIV Isolation and Characterization was established for the surveillance of HIV variability in Brazil. Here, we report characterization of HIV strains and virus-specific immune responses from 35 clinical samples collected from three potential HIV vaccine sites. Three genetic subtypes of HIV-1 were identified by heteroduplex mobility assay (HMA) B (in 82.9% of the samples), F (14.3%), and C (2.9%). Phylogenetic analysis based on the C2V3/env DNA sequence from all 25 specimens examined was 100% concordant with HMA results. Four variants of subtype B with different tetrapeptides at the tip of the V3 loop were found: the GPGR motif (North American), GWGR motif (Brazilian B"), and two minor variants, GFGR and GPGS, as previously detected. No significant association was found between HIV-1 subtypes and the mode of transmission or biologic properties of HIV-1 isolates (derived from 88.6% of the specimens). Only 5 of 16 isolates studied were neutralized by the autologous sera. Consistent with previous results, no relation between viral subtype and peptide enzyme-linked immunosorbent assay (ELISA) seroreactivity or neutralization was evident. This study also demonstrated the effectiveness of the collaborative approach followed by Brazilian scientists when addressing a complex subject such as HIV variability.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines*
  • Adolescent
  • Adult
  • Amino Acid Sequence
  • Brazil / epidemiology
  • Female
  • HIV Envelope Protein gp120 / analysis
  • HIV Infections / epidemiology*
  • HIV Infections / virology
  • HIV-1 / classification*
  • HIV-1 / genetics
  • HIV-1 / immunology
  • Humans
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Peptide Fragments / analysis
  • Phylogeny
  • Risk Factors
  • Sequence Analysis

Substances

  • AIDS Vaccines
  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments

Associated data

  • GENBANK/AF060952
  • GENBANK/AF060953
  • GENBANK/AF060954
  • GENBANK/AF060955
  • GENBANK/AF060956
  • GENBANK/AF060957
  • GENBANK/AF060958
  • GENBANK/AF060959
  • GENBANK/AF060960
  • GENBANK/AF060961
  • GENBANK/AF060962
  • GENBANK/AF060963
  • GENBANK/AF060964
  • GENBANK/AF060965
  • GENBANK/AF060966
  • GENBANK/AF060967
  • GENBANK/AF060968
  • GENBANK/AF060969
  • GENBANK/AF060970
  • GENBANK/AF060971
  • GENBANK/AF062422
  • GENBANK/AF062423
  • GENBANK/AF062424
  • GENBANK/AF062425